Cargando…
Development of novel SARS-CoV-2 viral vectors
The authentic SARS-CoV-2 requires to be handled in Biosafety Level 3 laboratories, which restrains investigation by the broader scientific community. Here, we report the development of a novel SARS-CoV-2 viral vector composed of all 4 SARS-CoV-2 structural proteins, the packaging signal sequence of...
Autores principales: | Liu, Huan, Liu, Dexi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421939/ https://www.ncbi.nlm.nih.gov/pubmed/37567900 http://dx.doi.org/10.1038/s41598-023-40370-8 |
Ejemplares similares
-
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
por: Li, Qianqian, et al.
Publicado: (2020) -
Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
por: Liu, Xiao-Huan, et al.
Publicado: (2022) -
Development of a charged model of the SARS-CoV-2 viral surface
por: Parker, James E., et al.
Publicado: (2023) -
Development and validation of viral load assays to quantitate SARS-CoV-2
por: Bland, Joshua, et al.
Publicado: (2021) -
SARS-CoV-2 and viral sepsis: observations and hypotheses
por: Li, Hui, et al.
Publicado: (2020)